Skip to content
Search

Latest Stories

Pharmacy contractors eye PCN sites for Covid-19 jabs even as GPs get new guidance on extra dose

While general practitioners have been given new guidance allowing them to use Pfizer Inc’s extra Covid-19 vaccine doses “at their discretion”, many community pharmacy contractors have submitted "hundreds of expressions of interest" to run the programme at PCN designated vaccination sites.

Incidentally, the Pfizer vaccine vials are supposed to hold five doses, according to the labelling, but media reports said pharmacists had found a way for a sixth or even a seventh dose. Without clear approval from the manufacturer, the extra dose had to be discarded however.


In a weekly webinar on Thursday (Dec 17) NHS England told GPs they could use the sixth dose “at their discretion,” following media reports that the MHRA was looking at the feasibility of getting six vaccines doses out of the Pfizer vials and was consulting with NHS about it.

Meanwhile, according to the Pharmaceutical Services Negotiating Committee, NHS regional teams are currently working with contractors that submitted proposals for areas where additional capacity is required, to assess whether the sites can be approved to participate in the vaccination programme.

It said some of the the first sites have started to vaccinate patients this week, with pharmacy contractors playing their part in supporting the wider PCN endeavour to start vaccinating the most vulnerable patients.

One of PSNC's regional representatives and Sheffield contractor Garry Myers on Tuesday (Dec 15) started vaccinating patients, alongside colleagues at his local PCN vaccination site.

“It was great to get going with administering Covid-19 vaccines with my PCN and general practice colleagues, knowing that this will have a really positive impact for the most vulnerable patients in the community I serve," he said.

“It is great to be one of the first community pharmacists in the world to administer the Pfizer/BioNTech vaccine, but I know many of my colleagues are really keen to play their part too over the coming weeks. Hopefully the practical challenges seen with the current vaccine will lessen as more vaccines are authorised for use, increasing the ability of community pharmacy teams to play a larger role in the programme.”

Others have joined Myers too, said PSNC.

Shilpa Shah, CEO of Kent LPC, mobilised five community pharmacy independent prescriber volunteers to work with and support East Kent Hospitals University NHS Foundation Trust to issue patient specific directions (PSDs) for the Covid vaccine.

The independent prescribers signing these PSDs allowed the first batch of Covid-19 vaccine to be administered to patients in Kent and Medway. Feedback from the Foundation Trust was very positive, saying this work really made a difference.

Alastair Buxton, PSNC director of NHS Services, commented: “It is fantastic to see community pharmacists already playing their part in the Covid-19 vaccination programme and the many pharmacy contractors that have said they would like to run a vaccination site demonstrates the appetite of the sector to participate in the programme and help the country recover from the pandemic.

“The vaccination programme will not be without its challenges, but community pharmacists and their teams are used to overcoming hurdles to provide the best care to their patients, so we believe their skills should be used by the NHS to help administer the tens of millions of vaccinations that will be needed to help England escape from the grip of the pandemic.”

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less